Prostate Cancer
Peter Scardino, MD, chief of surgery at Memorial Sloan-Kettering Cancer, talks about the practicality of prostate cancer screening
December 12, 2012
(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy - Abstract
December 12, 2012
Epidemiology and risk factors of the prostate cancer - Abstract
December 12, 2012
The art and science of medicine: Advanced treatment for prostate cancer
December 12, 2012
FDA expands Zytiga’s use for late-stage prostate cancer
December 11, 2012
Prognostic factors in Chinese patients with metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy - Abstract
December 11, 2012
Radiotherapy in the treatment of advanced and recurrent prostate cancer - Abstract
December 11, 2012
Increased risk of cancer mortality associated with cadmium exposures in older americans with low zinc intake - Abstract
December 11, 2012
Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy - Abstract
December 11, 2012
Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: Results from an Italian biopsy cohort - Abstract
December 11, 2012
Educating men about prostate cancer in the workplace - Abstract
December 11, 2012